Denali Therapeutics Inc. (DNLI) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Core Insights - Denali Therapeutics is participating in TD Cowen's 46th Annual Healthcare Conference, indicating its active engagement in the biotech sector [1] - The company is represented by its Co-Founder, CFO, and COO, Alex Schuth, highlighting the leadership's involvement in investor relations [1] Company Overview - A high-level overview of Denali Therapeutics is requested, focusing on the company's current status and expectations for the remainder of 2026 [2]